Advanced Medical Isotope Corporation (OTCMKTS:RDGL – Get Free Report) saw a large increase in short interest during the month of October. As of October 15th, there was short interest totaling 3,748 shares. Based on an average trading volume of 2,270,533 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the shares of the company are short sold.
Advanced Medical Isotope Stock Performance
Shares of Advanced Medical Isotope stock opened at $0.04 on Friday. The stock has a market capitalization of $22.14 million, a P/E ratio of -4.48 and a beta of -0.56. Advanced Medical Isotope has a 52-week low of $0.04 and a 52-week high of $0.12. The stock’s 50-day simple moving average is $0.05 and its 200 day simple moving average is $0.06.
Advanced Medical Isotope Company Profile
Advanced Medical Isotope Corp. (OTCMKTS:RDGL) is a medical technology company developing isotope-based treatments for cancer and other localized medical conditions. Its work centers on targeted radiation therapies designed to deliver radioactive material directly to tumors while limiting exposure to surrounding healthy tissue.
The company’s principal product platform is Radiogel, an injectable, biodegradable gel intended to deliver therapeutic radioisotopes locally within solid tumors.
Further Reading
- Five stocks we like better than Advanced Medical Isotope
- L3Harris Stock Took a Beating—Is a 20% Rebound Next?
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
Receive News & Ratings for Advanced Medical Isotope Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Isotope and related companies with MarketBeat.com's FREE daily email newsletter.
